A lot of people are going to get rich(er) at this tiny Wall Street firm
The firm has landed roles on some of the biggest deals of the year, working on the Pfizer-Allergan $160 billion megadeal.
It also has a role on the $20 billion Jarden-Newell Rubbermaid deal announced this week.
The firm has worked on deals worth $464 billion so far this year, and has hauled in more than $500 million in revenue from M&A deals, according to estimates from Dealogic.
To put that into context, Centerview lists 31 partners on its website. That works out at $16.4 million in revenue per partner.
According to various estimates, the boutique has between 200 and 225 employees. Even using the high range of that estimate, it means that on $508 million, Centerview made an average of more than $2.25 million per worker on its mega-M&A year.
Business Insider's Ben Moshinsky revealed details on Centerview's UK business earlier this week. The firm paid its top UK partner an £8 million ($12 million) profit share in 2015, according to its accounts.
Those accounts showed an operating profit of £18.6 on revenues of £26.3 million, giving it an operating margin of 71%. Almost all of that operating profit was paid out to members in compensation.
